For children with unilateral Wilms tumor, the most common primary malignant kidney cancer in childhood, the surgical decisions that determine outcomes have long varied between surgeons and institutions. A new expert consensus, developed by the Oncology Surgery Group and Urology Surgery Group of the Pediatric Surgery Branch of the Chinese Medical Association, sets out a standardized framework to address that variability. Published in World Journal of Pediatric Surgery on 17 June 2026, the guidance offers 34 recommendations based on 17 clinical questions, covering everything from upfront surgery versus preoperative chemotherapy to lymph node sampling, tumor thrombus, and minimally invasive surgery.
The consensus matters because nonstandard procedures can cause tumor rupture, incomplete staging, recurrence, and iatrogenic progression. While outcomes for Wilms tumor have improved substantially through advances in molecular diagnosis, chemotherapy, radiotherapy, and surgery, surgical management remains inconsistent, especially for large tumors, adjacent-organ invasion, intravascular extension, and nephron-sparing surgery. Surgeons also come from different specialties, which may contribute to practice variation. The new framework seeks to reduce those harms while preserving renal function and improving long-term outcomes.
Among the key recommendations, immediate radical nephrectomy is advised for resectable tumors, whereas preoperative chemotherapy is preferred for selected patients with high-risk or initially unresectable disease. Immediate surgery is discouraged in certain circumstances, including confirmed germline WT1 mutation, solitary kidney, severe anesthetic risk, or tumor thrombus above the hepatic veins. Percutaneous biopsy is generally not recommended but is suggested when renal origin is unclear, benign or non-WT disease is suspected, or in stage IV patients and those older than 10 years. The consensus also stresses adequate lymph node sampling—ideally 6 to 10 nodes from specified sites—to improve staging and keep the false-negative rate below 10%, along with early ligation of renal pedicle vessels and preservation of adjacent organs unless directly invaded.
For complex scenarios such as tumor thrombus extending into the atrium, recurrent disease, and unusual presentations, the authors emphasize multidisciplinary discussion. They also caution that nephron-sparing surgery is not routine and requires strict criteria, and that minimally invasive surgery may be considered only in selected cases at experienced centers, with conversion to open surgery viewed as sound judgment rather than failure. The full recommendations are available in the published article (DOI: 10.1136/wjps-2026-001204).
The implications extend beyond individual surgeons. By aligning care around common standards, the consensus can help pediatric surgeons, oncologists, urologists, radiologists, and pathologists coordinate preoperative risk assessment, appropriate chemotherapy, adequate lymph node sampling, organ-preserving approaches when safe, and structured follow-up. In resource-limited settings, the framework may also guide referral and multidisciplinary planning. The authors call for future studies to refine patient selection for nephron-sparing and minimally invasive surgery, improve rupture prediction, standardize lymph node mapping, and clarify anticoagulation and radiotherapy decisions. Ultimately, the consensus aims to support more consistent, individualized care for children with unilateral Wilms tumor, with the goal of safer surgery, better staging, and fewer avoidable recurrences.


